Compare Medpace Holdings Inc (MEDP) vs Packaging Corporation of America (PKG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Packaging Corporation of America — how do they compare? Medpace Holdings Inc trades at $519.93 (market cap $15.08B), while Packaging Corporation of America trades at $228.17 (market cap $20.77B). The key difference: Packaging Corporation of America is the larger of the two by market cap, and Packaging Corporation of America pays a 2.57% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | PKG | |
|---|---|---|
Market Cap | $15.08B | $20.77B |
Sector | Technology | Technology |
52-Week High | $620.59 | $246.31 |
52-Week Low | $308.88 | $191.41 |
Enterprise Value | $14.55B | $24.59B |
Dividend Yield | — | 2.57% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
Packaging Corporation of America (PKG) trades at $228.43, down 1.99% today, with mixed technical signals showing bullish moving averages but neutral oscillators. The company reported Q1 2026 EPS of $2.40, beating estimates, but faces margin pressure with net income expected to decline to $741 million in 2026. Recent developments include a 20% dividend increase and upcoming Q2 earnings on July 22, 2026.
PKG presents a balanced outlook with strong institutional support and dividend growth offset by earnings volatility and margin compression. The consensus price target of $256.14 suggests 12% upside potential, but investors should monitor Q2 results and cost management amid inflationary pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →
